EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma. Shi, W., Kleinberg, L., Jeyapalan, S. A., Goldlust, S. A., Nagpal, S., Combs, S. E., Roberge, D., Nishigawa, R., Grossman, R., Glas, M. AMER ASSOC CANCER RESEARCH. 2021

View details for Web of Science ID 000680263501370